Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this proof of concept study is to evaluate the safety and efficacy of the
off-label use of Aimovig® (EREN) in reducing Temporomandibular Disorder (TMD) pain compared
to placebo.